Evidence map›Paper›PMID 33602710›Full record

ArticleBMJ open2021

Prescribed exercise regimen versus usual care and hypochlorous acid wound solution versus placebo for treating venous leg ulcers: study protocol for a randomised controlled trial (Factorial4VLU).

Andrew Jull, Angela Wadham, Chris Bullen, Varsha Parag, John G M Parsons, George Laking, Jill Waters, Markos Klonizakis, Jane O'Brien

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Andrew JullSchool of Nursing, University of Auckland, Auckland, New Zealand a.jull@auckland.ac.nz.ORCID 0000-0002-8484-3771
Angela WadhamNational Institute for Health Innovation, University of Auckland, Auckland, New Zealand.
Chris BullenNational Institute for Health Innovation, University of Auckland, Auckland, New Zealand.ORCID 0000-0001-6807-2930
Varsha ParagNational Institute for Health Innovation, University of Auckland, Auckland, New Zealand.
John G M ParsonsSchool of Nursing, University of Auckland, Auckland, New Zealand.
George LakingBlood and Cancer Directorate, Auckland District Health Board, Auckland, New Zealand.
Jill WatersHope Foundation for Research on Ageing, Auckland, New Zealand.
Markos KlonizakisCentre for Sport and Exercise Science, Sheffield Hallam University, Sheffield, UK.
Jane O'BrienSchool of Nursing, University of Tasmania, Launceston, Tasmania, Australia.
University of Auckland · NZAuckland District Health Board · NZHope Foundation for Research on Ageing · NZSheffield Hallam University · GBUniversity of Tasmania · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCompression is the mainstay of treatment for venous leg ulcers (VLUs) and there are few effective adjuvant treatments. There is only observational evidence supporting the use of hypochlorous acid (HOCl) as a topical wound solution on VLU and some limited randomised evidence for the effect of a prescribed regimen of exercise. METHODS AND ANALYSIS: The Factorial4VLU trial is a pragmatic, blinded, factorial randomised controlled trial, with 380 participants receiving either a prescribed exercise regimen compared with usual care and either active HOCl wound solution or placebo wound solution at each dressing change for up to 24 weeks. All participants will receive compression therapy. The primary outcome is the proportion of participants with healed VLU at 12 weeks after randomisation as adjudicated by blinded review of ulcer photographs. Secondary outcomes are proportion healed at 24 weeks, time to healing, estimated change in ulcer area, change in 2-Minute Walk Test, change in health-related quality of life, incidence of infection and incidence of all-cause adverse events. If either of the interventions shows a statistically significant positive difference on healing outcomes, cost-effectiveness will be modelled using a health service perspective. ETHICS AND DISSEMINATION: The Factorial4VLU trial received ethical approval from the Northern B Health and Disability Ethics Committee. We plan to publish the results within 1 year of trial completion and will include the results on the trial registration page. TRIAL REGISTRATION NUMBERS: Australia and New Zealand Clinical Trials Register (http://www.anzctr.org.au) (ACTRN12620000116921); Universal Trial Number (WHO) (U1111-1236-2997).

Indexed as

Hypochlorous AcidVaricose UlcerAustraliaHumansNew ZealandPragmatic Clinical Trials as TopicQuality of LifeRandomized Controlled Trials as TopicHypochlorous Acidclinical trialsprimary carewound management

Identifiers

PMID33602710
PMCPMC7896607
OpenAlexW3132472834

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.